BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 18344241)

  • 21. Delivery of megsin siRNA plasmid reveals therapeutic potential against diabetic nephropathy by down-regulating p27(kip1) level.
    Liu M; Zhang Y; Chi Y; Zhai S; Wang B; Shi Y; Li Y
    J Nephrol; 2012; 25(3):418-25. PubMed ID: 21928229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advanced glycation endproducts induce podocyte apoptosis by activation of the FOXO4 transcription factor.
    Chuang PY; Yu Q; Fang W; Uribarri J; He JC
    Kidney Int; 2007 Oct; 72(8):965-76. PubMed ID: 17667983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of receptor for advanced glycation end-products and signalling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytes.
    Gu L; Hagiwara S; Fan Q; Tanimoto M; Kobata M; Yamashita M; Nishitani T; Gohda T; Ni Z; Qian J; Horikoshi S; Tomino Y
    Nephrol Dial Transplant; 2006 Feb; 21(2):299-313. PubMed ID: 16263740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
    Susztak K; Raff AC; Schiffer M; Böttinger EP
    Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of adenovirus-mediated p27kip1 lacking the Jab1-binding region enhances cytotoxicity and inhibits xenografted human cholangiocarcinoma growth.
    Shiraso S; Katayose Y; Yamamoto K; Mizuma M; Yabuuchi S; Oda A; Rikiyama T; Onogawa T; Yoshida H; Hayashi H; Ohtsuka H; Motoi F; Egawa S; Kato J; Unno M
    Anticancer Res; 2009 Jun; 29(6):2015-24. PubMed ID: 19528460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular mechanism through which parathyroid hormone-related protein induces proliferation in arterial smooth muscle cells: definition of an arterial smooth muscle PTHrP/p27kip1 pathway.
    Fiaschi-Taesch N; Sicari BM; Ubriani K; Bigatel T; Takane KK; Cozar-Castellano I; Bisello A; Law B; Stewart AF
    Circ Res; 2006 Oct; 99(9):933-42. PubMed ID: 17023675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SP1-regulated p27/Kip1 gene expression is involved in terbinafine-induced human A431 cancer cell differentiation: an in vitro and in vivo study.
    Huang CS; Ho WL; Lee WS; Sheu MT; Wang YJ; Tu SH; Chen RJ; Chu JS; Chen LC; Lee CH; Tseng H; Ho YS; Wu CH
    Biochem Pharmacol; 2008 May; 75(9):1783-96. PubMed ID: 18355800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of high glucose and transforming growth factor-β on bioenergetic profiles in podocytes.
    Stieger N; Worthmann K; Teng B; Engeli S; Das AM; Haller H; Schiffer M
    Metabolism; 2012 Aug; 61(8):1073-86. PubMed ID: 22365040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of metabolic and haemodynamic factors in podocyte injury in diabetes.
    Stieger N; Worthmann K; Schiffer M
    Diabetes Metab Res Rev; 2011 Mar; 27(3):207-15. PubMed ID: 21309047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extract of the aerial parts of Aster koraiensis reduced development of diabetic nephropathy via anti-apoptosis of podocytes in streptozotocin-induced diabetic rats.
    Sohn E; Kim J; Kim CS; Kim YS; Jang DS; Kim JS
    Biochem Biophys Res Commun; 2010 Jan; 391(1):733-8. PubMed ID: 19944074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of epithelial sodium channel expression in renal cortical collecting ducts cells by advanced glycation end products.
    Chang CT; Wu MS; Tian YC; Chen KH; Yu CC; Liao CH; Hung CC; Yang CW
    Nephrol Dial Transplant; 2007 Mar; 22(3):722-31. PubMed ID: 17192279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antioxidants ameliorate the expression of vascular endothelial growth factor mediated by protein kinase C in diabetic podocytes.
    Lee EY; Chung CH; Kim JH; Joung HJ; Hong SY
    Nephrol Dial Transplant; 2006 Jun; 21(6):1496-503. PubMed ID: 16484238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Podocyte hypertrophy in diabetic nephropathy.
    Kim NH
    Nephrology (Carlton); 2005 Oct; 10 Suppl():S14-6. PubMed ID: 16174280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KIS induces proliferation and the cell cycle progression through the phosphorylation of p27Kip1 in leukemia cells.
    Nakamura S; Okinaka K; Hirano I; Ono T; Sugimoto Y; Shigeno K; Fujisawa S; Shinjo K; Ohnishi K
    Leuk Res; 2008 Sep; 32(9):1358-65. PubMed ID: 18384876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene expression patterns in glucose-stimulated podocytes.
    Han SH; Yang S; Jung DS; Li JJ; Kim JJ; Kwak SJ; Kim DK; Moon SJ; Lee JE; Han DS; Kang SW
    Biochem Biophys Res Commun; 2008 Jun; 370(3):514-8. PubMed ID: 18395008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease.
    Wolowiec D; Wojtowicz M; Ciszak L; Kosmaczewska A; Frydecka I; Potoczek S; Urbaniak-Kujda D; Kapelko-Slowik K; Kuliczkowski K
    Eur J Haematol; 2009 Apr; 82(4):260-6. PubMed ID: 19187271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parathyroid hormone-related protein is a hypertrophy factor for human mesangial cells: Implications for diabetic nephropathy.
    Ortega A; Romero M; Izquierdo A; Troyano N; Arce Y; Ardura JA; Arenas MI; Bover J; Esbrit P; Bosch RJ
    J Cell Physiol; 2012 May; 227(5):1980-7. PubMed ID: 21732369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. UCH-L1 induces podocyte hypertrophy in membranous nephropathy by protein accumulation.
    Lohmann F; Sachs M; Meyer TN; Sievert H; Lindenmeyer MT; Wiech T; Cohen CD; Balabanov S; Stahl RA; Meyer-Schwesinger C
    Biochim Biophys Acta; 2014 Jul; 1842(7):945-58. PubMed ID: 24583340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effect of GSPE on RAGE expression induced by advanced glycation end products in endothelial cells.
    Zhang FL; Gao HQ; Shen L
    J Cardiovasc Pharmacol; 2007 Oct; 50(4):434-40. PubMed ID: 18049312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impairment of human keratinocyte mobility and proliferation by advanced glycation end products-modified BSA.
    Zhu P; Yang C; Chen LH; Ren M; Lao GJ; Yan L
    Arch Dermatol Res; 2011 Jul; 303(5):339-50. PubMed ID: 21132435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.